EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Validation of drug‐resistant epilepsy identification algorithms in US Veterans across diverse care settings

Zulfi Haneef, Rohan S. Nagabhirava, Andrea D. Hildebrand, Richard Zhou, Sruthi Gopinath Karicheri, Stephan Eisenschenk, Marcella A. Coutts, Maria Raquel Lopez, Omar I. Khan, Rizwana Rehman, Zehra Husain, Manuel Melo Bicchi und 28 weitere

Epilepsia · 18.11.2026

DOI: 10.1002/epi.70580 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, online erschienen am 18.11.2026. Verfasst von Zulfi Haneef und 39 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Early recognition of drug‐resistant epilepsy (DRE) is critical for timely referral to comprehensive epilepsy centers (CECs). Our prior pilot study in the Veterans Health Administration (VHA) demonstrated the feasibility of an algorithm‐based approach to identify DRE within selected CECs. In this study, we validated and refined these algorithms in a broader, national cohort, including CEC and non‐CEC care, to optimize algorithms for different care settings.

Methods

We conducted a multicenter, retrospective study of randomly sampled veterans with epilepsy on ≥2 antiseizure medications (ASMs) from 1999 to 2024. Chart review by 26 epilepsy providers rated DRE status. Ninety‐six candidate algorithms using combinations of six criteria—number of ASMs, treatment duration, dose thresholds, pregabalin exclusion, intractable International Classification of Diseases (ICD) codes, and electroencephalography (EEG)/magnetic resonance imaging (MRI) utilization—were evaluated. Performance for DRE classification was evaluated among all veterans, and separately for CEC or non‐CEC care.

Results

Among 970 veterans on ≥2 lifetime ASMs, 518 (53.4%) were rated as DRE, 363 (37.4%) as non‐DRE, and 89 (9.2%) as undetermined. Veterans with DRE were younger (mean age = 68.9 vs. 72.0 years) and more frequently had at least one intractable ICD code (46.1% vs. 18.2%), EEG (77.8% vs. 66.7%), or MRI (78.0% vs. 65.8%) compared with non‐DRE (all p ‐values

Zitieren

APA

Haneef, Z., Nagabhirava, R. S., Hildebrand, A. D., Zhou, R., Karicheri, S. G., Eisenschenk, S., Coutts, M. A., Lopez, M. R., Khan, O. I., Rehman, R., Husain, Z., Bicchi, M. M., Reeder, S., Rincon‐Flores, N., Zimmerman, C., Gaston, T. E., Narechania, A., Tran, T., Kaska, R., …, & Hill, C. E. (2026). Validation of drug‐resistant epilepsy identification algorithms in US Veterans across diverse care settings. Epilepsia. https://doi.org/10.1002/epi.70580

Vancouver

Haneef Z, Nagabhirava RS, Hildebrand AD, Zhou R, Karicheri SG, Eisenschenk S, et al. Validation of drug‐resistant epilepsy identification algorithms in US Veterans across diverse care settings. Epilepsia. 2026. doi:10.1002/epi.70580

BibTeX
@article{Haneef2026,
  author = {Haneef, Zulfi and Nagabhirava, Rohan S. and Hildebrand, Andrea D. and Zhou, Richard and Karicheri, Sruthi Gopinath and Eisenschenk, Stephan and Coutts, Marcella A. and Lopez, Maria Raquel and Khan, Omar I. and Rehman, Rizwana and Husain, Zehra and Bicchi, Manuel Melo and Reeder, Stephanie and Rincon‐Flores, Noemi and Zimmerman, Christopher and Gaston, Tyler E. and Narechania, Aditi and Tran, Tung and Kaska, Rebekah and Roach, Alexandra and Mefford, Anthony and Smith, Christine and Surabhi, Swapna and Birnbaum, Daniel and Sebasigari, Denise and Waterhouse, Elizabeth J. and Ahn, Francisca and Kayal, Gina and Dave, Hina and Pellinen, Jacob and Hirschey, Jacqueline and Patel, Kamakshi and Medin, Karen and Fadipe, Melissa and Ono, Kenichiro and Pugh, Mary Jo and Towne, Alan R. and Tobochnik, Steven and Durica, Sarah R. and Hill, Chloe E.},
  title = {Validation of drug‐resistant epilepsy identification algorithms in US Veterans across diverse care settings},
  journal = {Epilepsia},
  year = {2026},
  doi = {10.1002/epi.70580}
}
Kostenlos starten →